Trial Profile
Safety, tolerability and pharmacokinetics of oral contezolid acefosamil in healthy volunteers: A phase I multiple ascending dose study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs Contezolid-acefosamil (Primary)
- Indications Gram-positive infections
- Focus Adverse reactions; Pharmacokinetics
- 03 May 2018 New trial record
- 24 Apr 2018 Results presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases